Practice tip: Avoid the practice sale pitfall of mismanagement of payment terms
“Practice purchases often produce a variation in terms of payment. Is the practice purchase paid to the OD seller in one lump sum, or is it stretched out over time?” writes Allan Barker, OD, and Greg Stockbridge, OD, MBA, in “Preventing practice sales transaction pitfalls.” Consider that the buyer who stretches payments out over time can ruin a practice and subsequently not pay the installment obligations, the article’s authors point out. As a result, they urge practice sellers to always remember that the seller who gets the money up front has the money to reinvest, start earning dividends, interest, or pay off debt obligations. Read more.  

Alcon and World Council of Optometry launch more online resources for Dry Eye Wheel
Alcon and the World Council of Optometry released new online resources to help eyecare professionals use their Dry Eye Wheel, a tool that aids in the diagnosis and treatment of dry eye disease. The resources include videos that explain the best way to integrate the Wheel into ECPs’ daily practice and Spanish captioning for the website’s educational webinars. To use the wheel and discover other dry eye disease resources, visit dryeye.worldcouncilofoptometry.info/interactive-dry-eye-wheel. 

CEVR and SCOPE announce partnership for development of dry eye disease technology
The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. have established a collaborative partnership to develop technologies for dry eye disease and other ocular surface conditions, according to a press release. Specifically, the duo plan to leverage SCOPE’s knowledge in eye drop product formulation science with CEVR’s experience in ocular drug discovery and delivery translational research to develop products to meet ocular surface disease needs.  

SightGlass Vision’s Diffusion Optics Technology the topic of several recent journal articles
Three new published peer-reviewed papers are expanding the scientific evidence of SightGlass Vision’s Diffusion Optics Technology for myopia management with children. These publications:

• In BMJ Open Ophthalmology, “Control of myopia using optics spectacle lenses: 4-year results of a multicentre randomized controlled, efficacy and safety study CYPRESS),” available here.
• In Ophthalmic & Physiological Optics, “Visual impact of diffusion optic technology lenses for myopia control,” available here.
• In Translational Vision Science & Technology, “Diffusion optics technology (DOT): a myopia control spectacle lens based on contrast theory,” available here.

SightGlass is currently unavailable in the United States. 

The Vision Council publishes standard requirements for eye protection devices
for pickleball, tennis, etc.
The Vision Council announced the publication of an updated standard, ASTM F3164-24, which provides performance requirements for both plano and prescription eye protection devices specifically designed for racquetball, squash, tennis, and pickleball. The specifications cover eye protectors, frame and lens minimum robustness requirements, optics requirements, and downstream prescription-filling requirements for optical laboratories and opticians/dispensers prior to delivery. A copy of the standard can be purchased through ASTM, and members of The Vision Council can learn more about industry technical standards here. 

Vision Rehab Technologies Inc. debuts artificial-intelligence-powered eye care assessments 
Vision Rehab Technologies Inc. (VRTI) has made available its WIVIVision product to North American eyecare providers. WIVIVision utilizes artificial intelligence (AI) and a gamified, 3D immersive system that integrates video games to offer screenings, comprehensive assessments, and rehabilitation tools to identify and treat patients who have visual dysfunctions, according to a press release. As a result, ECPs can efficiently assess eye teaming, tracking, and accommodation, all of which are essential for addressing binocular vision and other visual performance challenges, according to the company. For more information, visit wivivision.com

WHO and OneSight EssilorLuxottica Foundation to collaborate on refractive error coverage initiative
OneSight EssilorLuxottica Foundation will collaborate with the World Health Organization (WHO) on the WHO’s SPECS 2030 initiative. Specifically, the initiative builds on the global target to increase effective refractive error coverage by 40% by 2030, which was endorsed by WHO Member States in 2021 at the World Health Assembly. The collaboration will focus on knowledge sharing, technical input, and data provision to scale impactful solutions and ensure the effective implementation of the United Nations’ Vision for Everyone resolution. OM